
The Doctor Who Doesn’t Scale
I spend a good deal of my working life around founders and entrepreneurs, and I have noticed something about people who are very good at building things that scale. When something goes wrong with their own health, they usually want something remarkably unscalable.
A Particular Doctor.
When a scan comes back with a sentence in it nobody wanted, the question is rarely which hospital or which clinic or which telehealth platform should I use? It is quieter than that, usually asked of a friend: who do you see? They want a name — someone senior, reachable, unhurried, whose judgment they can borrow when the situation refuses to fit the pathway. There is a contradiction here, though not a hypocrisy.
These are people who build businesses precisely by removing dependence on particular individuals. Yet when something frightening happens in their own body, they go looking for a particular individual. Some forms of value scale through replication. Others are made of attention. We seem to understand the distinction intuitively when something important is at stake.

Occasionally the same man, in the same conversation, will ask why I don't scale the practice. It is friendly advice, generously meant, and I take it that way. But there is something almost tender in the question, because he is recommending the dismantling of the very thing he came for. He knows this. It is why he wanted a name and not a platform.
He wants me to scale. He just doesn't want his doctor to.
I have been on the other side of that lesson, which is perhaps why I notice it. Years ago, in an earlier practice, I did what sensible practice owners do. I grew — more clinics, more rooms, more doctors, more capacity. And some of my most loyal and most engaged patients were unhappy about it. Financially successful patients who had scaled their own businesses or successful leaders who lead large organisations several times over were unmistakably aggrieved that I had scaled and expanded mine.
At the time I found this puzzling, even a little unfair. Nothing about what they paid had changed. What had changed was quieter. They waited longer. They saw my colleagues. They had less certainty that I would be the person in the room when something wrong happened.
Scarcity of Time, Continuity and Access
It took me longer than it should have to understand what they were reacting to. I had measured the growth in capacity; they had experienced it as a reduction in attention. Both were true. I had assumed I was scaling the service. From their side of the desk, I was diluting it.
The scarce currency in the relationship was never really money. It was time, continuity and access, and I had increased supply by reducing the concentration of the thing they valued. That experience sits underneath most of what follows, because attention is not only difficult to scale. It changes what the doctor is able to do.
The same instinct that built the company follows these men into the consulting room, and mostly it serves them well. Many of the men I look after are unusually good at making things better; it is unsurprising that eventually they turn the talent on themselves. Measure, compare, find the constraint, improve the variable. In preventive medicine these habits produce engaged, curious patients who act early. It is a far better starting point than the man who avoids doctors on principle.
But optimisation has a property worth naming. It has no natural stopping rule. His LDL is good — could it be lower? His testosterone is normal — could it be higher? His sleep is fine, but the wearable disagrees. His cardiovascular risk is low — what haven't we measured?
None of these questions is unreasonable, which is exactly what makes them interesting. There is always another biomarker to improve, another percentile to enter, another risk to reduce. At some point the doctor has to decide whether he is still treating the patient or merely collaborating with his inability to leave himself alone. Medicine sometimes has to supply the stopping rule that optimisation lacks.
When Everyone Needs You to Perform
And consider who else is in the room, so to speak. His board needs him to perform. His investors do too. His employees depend on it. His coach improves his performance, his trainer improves his body, his wearable scores his sleep and delivers the verdict over breakfast. The same shape follows the surgeon into tomorrow's operating list, the senior barrister into a trial, the political leader into a room where everyone is waiting for a decision.
When enough people depend on someone's continued functioning, even genuine concern can turn quietly instrumental — are you all right? Support has become a proxy to the organisational success - are you all right enough to keep going? Almost everyone around him has some legitimate interest in what he is capable of doing.

There is a peculiar danger for medicine here. Done badly, performance medicine becomes one more institution making demands of the patient — sleep better, get leaner, raise this, lower that, recover faster, live longer. Even health becomes another domain in which he is expected to perform. I don't think the doctor should always join that chorus.
If poor sleep or hypertension or low mood is genuinely impairing his life, we treat it, and we treat it properly. But the obligation is different. It takes knowledge to know when intervention matters, judgment to know when it doesn't, and occasionally nerve to say so. Sometimes it takes nerve to simply say - you are well, and this is what well looks like.
Which raises a question I have been carrying around for a while. If almost everyone around him has some legitimate interest in his continued functioning, who is responsible for simply looking after him?
The Doctor's Seat
I have come to think that is the doctor's distinct seat at the table. His doctor may care about his performance. His doctor cannot ultimately be responsible to it.
There is something else the consulting room offers such men, and it is easy to underestimate. The more consequential a person's position becomes, the harder it is for anyone to interact with him without also interacting with the role. He is still the founder when he talks to his investors, still the chief executive in front of his own people. At home he may be a husband or a father rather than a CEO, but even the people who love him are not untouched by what happens if he becomes seriously unwell. They are frightened too.
The consulting room is one of the few places where the role can be set down. It is a place where, for a while, he is allowed to be ordinary. He does not have to reassure the board that everything is under control. He does not have to turn uncertainty into a plan or fear into a decision. He does not even have to reassure the people who love him.
He can simply say, I'm frightened.

For that hour, I am not responsible for the institution. I am responsible for him.
None of this makes me against scale, quite the opposite. I want screening to get better, data collection to become effortless, the tracking and pattern recognition to become extraordinarily good, and the people building that infrastructure are doing something important. Scale those things precisely so that we never have to scale the discretion and judgement part.
Because eventually the data runs out, and the final questions remain stubbornly individual. Someone has to know the evidence, know the patient, understand the stakes, and make a judgment.
The doctor shouldn't be another member of the optimisation team. There will already be enough people telling him what to do and how to do it better. Some of that work matters, and some of it will be mine. But somebody in his life should have no stake in how useful he remains. The doctor should simply be the one who knows him, and knows him well.

The men who text a friend for a name when the scan comes back — I think that is what they are looking for. Someone who knows the evidence and understands the stakes, but who, for that moment, wants nothing from him.
Not someone against the team. Someone whose seat at the table is different.
Dr Luke Wee is a private doctor working across Australia and New Zealand. He writes about longevity, medicine, and the less financially rewarding parts of being a doctor that do not scale. His own practice, increasingly by design, doesn't scale particularly well either.
First published in The Longer Consultation on LinkedIn, 31 August 2026. Cover photograph: Taylor Nicole on Unsplash.